NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Marty, I suggest you consider what's happening at the time before selling at $4. If you really don't think it's going much higher at the time, fine, sell, but if you like the potential of rising to double digits, and beyond, why sell.

My biggest complaint with many Analysts is when a stock reaches their target they lower their rating on it. Rating it a Hold is really a sell signal to those who buy on their new buy recommendations. When the stock doubles again the Analyst takes full credit for the entire gain, they told you to hold, if you held you'd have the entire gain. In my view when the target is hit it's time to reexamine the stock, if you can't raise your target at that point, say so, but perhaps the rating in that case should be sell rather than hold. On the other hand, if you raise your target by 10% or more, perhaps hold is justified, while putting a buy on a stock that should do better than that.

Analysts for the most part work from brokerage houses, therefore they push the stocks they're told to. The only broker I'd care to follow is one who's independent of brokers, but also has subject matter expertise. A poli-sci major does not constitute having medical expertise. I'm really not following anyone in particular right now, but used to like Jim McCammant's when he was around and writing his newsletter.

Gary